Skip to main content

Advertisement

SpringerLink
Log in

Retrospective Analysis of Clinicopathological Characteristics of Pregnancy Associated Melanoma

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Pregnancy associated melanoma (PAM) by definition appears during pregnancy or within 1 year after delivery. In this retrospective study we analysed the pathological characteristics and survival rate of PAM and matched the data with non-pregnant age- and stage-matched control patients. Between 2003 and 2014, 34 pregnant women (aged 32.5 ± 5.6 years) were diagnosed with melanoma at the Department of Dermatology, Venereology and Dermatooncology of the Semmelweis University. During the pathological process histologic subtype, Breslow thickness and Clark level, tumor cell type, mitotic rate, peritumoral inflammation, as well as ulceration, regression, necrosis, vascular invasion and presence of satellite were analyzed and related to clinical data. Primary tumor location and clinical staging, disease course, local recurrence and metastases, 5-year survival rate, other tumor development before or after the diagnosis of melanoma have also been documented. We found no difference in all parameters between pregnant and non-pregnant melanoma cases except peritumoral inflammation which was higher in PAM group, moreover the presence of mild inflammation was significantly higher in PAM group compared to non-pregnancy associated melanoma (NPAM) women group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tomao F, Papa A, Lo Russo G, Zuber S, Spinelli GP, Rossi L, Caruso D, Prinzi N, Stati V, Benedetti Panici P, Tomao S (2014) Correlation between fertility drugs use and malignant melanoma incidence: the state of the art. Tumour Biol 35(9):8415–8424

    Article  CAS  PubMed  Google Scholar 

  2. Driscoll MS, Grant-Kels JM (2007) Hormones, nevi, and melanoma: an approach to the patient. J Am Acad Dermatol 57(6):919–931, quiz 932–6

    Article  PubMed  Google Scholar 

  3. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM (2001) Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol 184(7):1504–1512, discussion 1512–3

    Article  CAS  PubMed  Google Scholar 

  4. Zick CD, Smith KR, Mayer RN, Taylor LB (2014) Family, frailty, and fatal futures? Own-health and family-health predictors of subjective life expectancy. Res Aging 36(2):244–266

    Article  PubMed  Google Scholar 

  5. Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N, Group EGW (2010) Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v266–v273

    Article  PubMed  Google Scholar 

  6. Andersson TM, Johansson AL, Fredriksson I, Lambe M (2015) Cancer during pregnancy and the postpartum period: a population-based study. Cancer

  7. Zhou JH, Kim KB, Myers JN, Fox PS, Ning J, Bassett RL, Hasanein H, Prieto VG (2014) Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol 36(1):74–79

    Article  PubMed Central  PubMed  Google Scholar 

  8. Stensheim H, Moller B, van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51

    Article  PubMed  Google Scholar 

  9. Eibye S, Kjaer SK, Mellemkjaer L (2013) Incidence of pregnancy-associated cancer in Denmark, 1977–2006. Obstet Gynecol 122(3):608–617

    Article  PubMed  Google Scholar 

  10. Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, Newton Bishop JA (2004) Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 22(21):4369–4375

    Article  PubMed  Google Scholar 

  11. Frishberg DP, Balch C, Balzer BL, Crowson AN, Didolkar M, McNiff JM, Perry RR, Prieto VG, Rao P, Smith MT, Smoller BR, Wick MR, C.o.A.P. Members of the Cancer Committee (2009) Protocol for the examination of specimens from patients with melanoma of the skin. Arch Pathol Lab Med 133(10):1560–1567

    PubMed  Google Scholar 

  12. Clayton SG (1946) Melanoma of the vulva with pregnancy. Proc R Soc Med 39(9):578–579

    Google Scholar 

  13. Moller H, Purushotham A, Linklater KM, Garmo H, Holmberg L, Lambe M, Yallop D, Devereux S (2013) Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma. Eur J Cancer 49(17):3686–3693

    Article  PubMed  Google Scholar 

  14. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RC, Stromberg AJ, Hagendoorn L, McMasters KM, Sunbelt Melanoma T (2006) Gender-related differences in outcome for melanoma patients. Ann Surg 243(5):693–698, discussion 698–700

    Article  PubMed Central  PubMed  Google Scholar 

  15. Sanlorenzo M, Ribero S, Osella-Abate S, Zugna D, Marenco F, Macripo G, Fierro MT, Bernengo MG, Quaglino P (2014) Prognostic differences across sexes in melanoma patients: what has changed from the past? Melanoma Res 24(6):568–576

    Article  PubMed  Google Scholar 

  16. Gamba CS, Clarke CA, Keegan TH, Tao L, Swetter SM (2013) Melanoma survival disadvantage in young, non-Hispanic white males compared with females. JAMA Dermatol 149(8):912–920

    Article  PubMed  Google Scholar 

  17. Nosrati A, Wei ML (2014) Sex disparities in melanoma outcomes: the role of biology. Arch Biochem Biophys 563C:42–50

    Article  Google Scholar 

  18. Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AM, Holzel D, Coebergh JW, Engel J, Munich Melanoma G (2011) Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 131(3):719–726

    Article  CAS  PubMed  Google Scholar 

  19. Kanda N, Watanabe S (2001) 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol 117(2):274–283

    Article  CAS  PubMed  Google Scholar 

  20. O’Meara AT, Cress R, Xing G, Danielsen B, Smith LH (2005) Malignant melanoma in pregnancy. A population-based evaluation. Cancer 103(6):1217–1226

    Article  PubMed  Google Scholar 

  21. Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ (2003) Pregnancy and early-stage melanoma. Cancer 97(9):2248–2253

    Article  PubMed  Google Scholar 

  22. Johansson AL, Andersson TM, Plym A, Ullenhag GJ, Moller H, Lambe M (2014) Mortality in women with pregnancy-associated malignant melanoma. J Am Acad Dermatol 71(6):1093–1101

    Article  PubMed  Google Scholar 

  23. Byrom L, Olsen C, Knight L, Khosrotehrani K, Green AC (2015) Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis. J Eur Acad Dermatol Venereol

  24. Travers RL, Sober AJ, Berwick M, Mihm MC Jr, Barnhill RL, Duncan LM (1995) Increased thickness of pregnancy-associated melanoma. Br J Dermatol 132(6):876–883

    Article  CAS  PubMed  Google Scholar 

  25. Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M (1999) Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression. Cancer 85(5):1067–1076

    Article  CAS  PubMed  Google Scholar 

  26. Ladanyi A, Somlai B, Gilde K, Fejos Z, Gaudi I, Timar J (2004) T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10(2):521–530

    Article  CAS  PubMed  Google Scholar 

  27. Fortes C, Mastroeni S, Manooranparanpampil T, Passarelli F, Zappala A, Marino C, Russo N, Michelozzi P (2015) Tumor-infiltrating lymphocytes predict cutaneous melanoma survival. Melanoma Res. 25(4)306–11

  28. Toth V, Somlai B, Harsing J, Hatvani Z, Karpati S (2013) Stage distribution of malignant melanomas in a Hungarian centre. Orv Hetil 154(25):969–976

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Hungarian Scientific Research Fund [OTKA 83023, 112612 and OTKA NN 114460].

Conflict to Interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Mária street 41, Budapest, 1085, Hungary

    Melinda Fábián, Veronika Tóth, Beáta Somlai, Judit Hársing, Enikő Kuroli, Fanni Rencz, Daniella Kuzmanovszki, József Szakonyi, Béla Tóth & Sarolta Kárpáti

  2. Semmelweis University, Doctoral School of Clinical Medicine, Üllői street 26, Budapest, 1085, Hungary

    Fanni Rencz

  3. Department of Helath Economics, Corvinus University of Budapest, Fővám square 8, Budapest, 1093, Hungary

    Fanni Rencz

Authors
  1. Melinda Fábián
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veronika Tóth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beáta Somlai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Judit Hársing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Enikő Kuroli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fanni Rencz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniella Kuzmanovszki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. József Szakonyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Béla Tóth
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sarolta Kárpáti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarolta Kárpáti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fábián, M., Tóth, V., Somlai, B. et al. Retrospective Analysis of Clinicopathological Characteristics of Pregnancy Associated Melanoma. Pathol. Oncol. Res. 21, 1265–1271 (2015). https://doi.org/10.1007/s12253-015-9961-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-015-9961-4

Keywords

Search

Navigation